Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Chemotherapy Reports|March 1, 1975
Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancerS Frytak, C G Moertel, A J Schutt, et al.
Medical and Pediatric Oncology|January 1, 1981
Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancerE T Creagan, K S Fountain, S Frytak, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomasJ H Edmonson, H J Long, S Frytak, et al.
Cancer Investigation|January 1, 1988
Necrotic lung and bronchopleural fistula as complications of therapy in lung cancerS Frytak, R E Lee, P C Pairolero, et al.
Cancer Research|September 1, 1979
A comparative clinical and immunological assessment of methanol extraction residue of Bacillus Calmette-Guérin versus placebo in patients with advanced cancerM J O'Connell, C G Moertel, R E Ritts, et al.
Mayo Clinic Proceedings|May 13, 1999
Cerebral toxicity in patients treated for small cell carcinoma of the lungR Fonseca, B P O'Neill, R L Foote, et al.
Cancer Treatment Reports|January 1, 1978
Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanomaD L Ahmann, J H Edmonson, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of maytansine in advanced breast cancerJ H Edmonson, J Rubin, L K Kvols, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Chemotherapy Reports|March 1, 1975
Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancerS Frytak, C G Moertel, A J Schutt, et al.
Medical and Pediatric Oncology|January 1, 1981
Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancerE T Creagan, K S Fountain, S Frytak, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomasJ H Edmonson, H J Long, S Frytak, et al.
Cancer Investigation|January 1, 1988
Necrotic lung and bronchopleural fistula as complications of therapy in lung cancerS Frytak, R E Lee, P C Pairolero, et al.
Cancer Research|September 1, 1979
A comparative clinical and immunological assessment of methanol extraction residue of Bacillus Calmette-Guérin versus placebo in patients with advanced cancerM J O'Connell, C G Moertel, R E Ritts, et al.
Mayo Clinic Proceedings|May 13, 1999
Cerebral toxicity in patients treated for small cell carcinoma of the lungR Fonseca, B P O'Neill, R L Foote, et al.
Cancer Treatment Reports|January 1, 1978
Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanomaD L Ahmann, J H Edmonson, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of maytansine in advanced breast cancerJ H Edmonson, J Rubin, L K Kvols, et al.
Pageof 11